MedPath
HSA Approval

POLIBROXOL TABLET 30 mg

SIN09305P

POLIBROXOL TABLET 30 mg

POLIBROXOL TABLET 30 mg

April 16, 1997

MD PHARMACEUTICALS PTE. LTD.

MD PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMD PHARMACEUTICALS PTE. LTD.
Licence HolderMD PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R05CB06

ambroxol

Manufacturer Information

MD PHARMACEUTICALS PTE. LTD.

POLIPHARM CO LTD

Active Ingredients

AMBROXOL HCl

30 mg

Ambroxol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLIBROXOL TABLET 30 mg - HSA Approval | MedPath